A cutting-edge Cloud Data Specialist seeks the coding talents of a Front End Developer who will be instrumental in building and maintaining data-driven user interfaces for metering data, dashboards, ...
A cutting-edge Cloud Data Specialist seeks the coding talents of a Front End Developer who will be instrumental in building and maintaining data-driven user interfaces for metering data, dashboards, ...
The jsPDF library for generating PDF documents in JavaScript applications is vulnerable to a critical vulnerability that allows an attacker to steal sensitive data from the local filesystem by ...
IT: Welcome to Derry‘s first season ends with a terrifying showdown between the very human heroes of Derry and the evil cosmic horror known simply as “It.” However, what initially seems to be just a ...
Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...
The biotech received the good news it was hoping for from a top national regulator. This concerned RP1, its advanced melanoma drug. Well before market open, Replimune announced that the U.S. Food and ...
Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...
The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...
On July 22, 2025, Replimune publicly announced that the U.S. Food and Drug Administration (FDA) had issued a "Complete Response Letter" (CRL) for its Biologics License Application (BLA) for RP1. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results